5-Year Outcomes with Cobimetinib plus Vemurafenib in BRAFV600 Mutation–Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study

DSpace Repository

5-Year Outcomes with Cobimetinib plus Vemurafenib in BRAFV600 Mutation–Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study

Author: Ascierto, Paolo A.; Dreno, Brigitte; Larkin, James; Ribas, Antoni; Liszkay, Gabriella; Maio, Michele; Mandala, Mario; Demidov, Lev; Stroyakovskiy, Daniil; Thomas, Luc; de la Cruz-Merino, Luis; Atkinson, Victoria; Dutriaux, Caroline; Garbe, Claus; Hsu, Jessie; Jones, Surai; Li, Haocheng; McKenna, Edward; Voulgari, Athina; McArthur, Grant A.
Tübinger Autor(en):
Garbe, Claus
Published in: Clinical Cancer Research (2021), Bd. 27, H. 19, S. 5225-5235
Verlagsangabe: Amer Assoc Cancer Research
Language: English
Full text: http://dx.doi.org/10.1158/1078-0432.CCR-21-0809
ISSN: 1557-3265
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)